價(jià)格 | ¥23700 |
包裝 | 1mg |
最小起訂量 | 1mg |
發(fā)貨地 | 上海 |
更新日期 | 2024-09-29 |
中文名稱:SARS-CoV-2 NSP8 重組蛋白 (His) | 英文名稱:SARS-CoV-2 NSP8 Protein (His) |
品牌: TargetMol | 產(chǎn)地: 美國(guó) |
保存條件: store at low temperature | Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6~12 month | Shipping with blue ice. | 產(chǎn)品類別: 抑制劑 |
貨號(hào): TMPJ-01428 |
名稱 | SARS-CoV-2 NSP8 Protein (His) |
描述 | Cleavage by the viral main protease, 3CLpro results in generating the nsp8 protein, The nsp8 protein has been shown to associate with several other nsps and to colocalize with these nsps in cytoplasmic complexes that are important for viral RNA synthesis. It forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers.Nsp8 was shown to have RNA-dependent RNA polymerase (RdRp) activity that could be involved in producing primers utilized by nsp12 which is normally accepted to be the RdRp for SARS-CoV. |
存儲(chǔ)條件 | store at low temperature | Lyophilized powder: -20~-80°C for 1 year | Solution: -80°C for 6~12 month | Shipping with blue ice. |
成立日期 | 2013-04-18 (12年) | 注冊(cè)資本 | 589.8595萬人民幣 |
員工人數(shù) | 100-500人 | 年?duì)I業(yè)額 | ¥ 1億以上 |
主營(yíng)行業(yè) | 中間體,天然產(chǎn)物,生物化工,化學(xué)試劑,生物技術(shù)服務(wù) | 經(jīng)營(yíng)模式 | 貿(mào)易,工廠,試劑,定制,服務(wù) |
產(chǎn)品名稱 | 價(jià)格 | 公司名稱 | 報(bào)價(jià)日期 | |
---|---|---|---|---|
詢價(jià) |
VIP1年
|
北京百普賽斯生物科技股份有限公司
|
2024-11-12 | |
詢價(jià) |
VIP2年
|
武漢佰樂博生物技術(shù)有限公司
|
2024-11-15 | |
詢價(jià) |
VIP4年
|
武漢艾美捷科技有限公司
|
2024-10-16 |